Loading…
Pharmacokinetics of the phage endolysin‐based candidate drug SAL 200 in monkeys and its appropriate intravenous dosing period
Summary SAL 200 is a new phage endolysin‐based candidate drug for the treatment of staphylococcal infections. An intravenous administration study was conducted in monkeys to obtain pharmacokinetic information on SAL 200 and to assess the safety of a short SAL 200 dosing period (
Saved in:
Published in: | Clinical and experimental pharmacology & physiology 2016-10, Vol.43 (10), p.1013-1016 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Summary
SAL
200 is a new phage endolysin‐based candidate drug for the treatment of staphylococcal infections. An intravenous administration study was conducted in monkeys to obtain pharmacokinetic information on
SAL
200 and to assess the safety of a short
SAL
200 dosing period ( |
---|---|
ISSN: | 0305-1870 1440-1681 |
DOI: | 10.1111/1440-1681.12613 |